Profile
| Metric | Value |
|---|---|
| Full Name | Bio-Techne Corporation |
| Ticker | NASDAQ: TECH |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | |
| Website | bio-techne.com |
| Employees | 3,100 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $64.58 | |
| Price, 1D Change | -0.72% | |
| Market Cap | $10B | |
| TTM Dividend Yield | 0.50% | |
| PE Ratio | 132.01 | |
| Beta | 1.21 | |
| Revenue | $1B | |
| Revenue, 1Y Change | +5.23% | |
| EPS | $0.46 | |
| EPS, 1Y Change | -56.06% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.08 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 4:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.46 | |
| EPS Estimate | N/A | $1.97 |
| EPS Est. Change | N/A | +329.59% |
| Revenue | $1.22B | |
| Revenue Estimate | N/A | $1.22B |
| Revenue Est. Change | N/A | +0.44% |
| Current Price | $64.58 | |
| Price Target | - | $70.00 |
| Price Tgt. Change | - | +8.39% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.78 | $1.05 | -41.27% | |
| $1.91 | $0.46 | -75.92% | |
| $1.97 | N/A | +329.59% | |
| $2.16 | N/A | +370.52% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.16B | $1.16B | -0.02% | |
| $1.22B | $1.22B | +0.11% | |
| $1.22B | N/A | +0.44% | |
| $1.30B | N/A | +6.93% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -14.11% | |
| Price, 3Y | -21.74% | |
| Market Cap, 1Y | -15.25% | |
| Market Cap, 3Y | -22.38% | |
| Revenue, 1Y | +5.23% | |
| Revenue, 3Y | +10.31% | |
| EPS, 1Y | -56.06% | |
| EPS, 3Y | -72.28% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $64.58 | |
| SMA 200 | $55.23 | |
| SMA 200 vs Price | -14.47% | |
| SMA 50 | $60.66 | |
| SMA 50 vs Price | -6.06% | |
| Beta | 1.21 | |
| ATR | $1.86 | |
| 14-Day RSI | 65.57 | |
| 10-Day Volatility | 33.49% | |
| 1-Year Volatility | 43.40% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.08 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 0.50% | |
| Total Dividend | $0.32 | |
| Dividends Paid | $50.39M | |
| Payout Ratio | 68.69% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $1.22B | |
| EPS | $0.46 | |
| Gross Profit | $790.27M | |
| Gross Margin | 64.80% | |
| Operating Profit | $102.26M | |
| Operating Margin | 8.38% | |
| Net Income | $73.36M | |
| Net Margin | 6.02% | |
| EBITDA | $212.16M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.18 | |
| Current Ratio | 3.46 | |
| Quick Ratio | 2.38 | |
| - | ||
| F-Score | 8 | |
| Altman Z-Score | 10.84 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 132.01 | |
| PS Ratio | 8.27 | |
| PB Ratio | 5.12 | |
| EV/EBITDA | 27.68 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $1.92B | |
| Cash & Equivalents | $162.19M | |
| Total Assets | $2.56B | |
| Current Assets | $608.30M | |
| Total Liabilities | $639.06M | |
| Current Liabilities | $175.85M | |
| Total Debt | $444.06M | |
| Short Term Debt | $14.10M | |
| Accounts Payable | $25.31M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.12B | |
| Operating Expenses | $688.02M | |
| Cost Of Goods Sold | $429.36M | |
| SG&A | $588.52M | |
| D&A | $109.90M | |
| Interest Expense | $0.00 | |
| Income Tax | $25.06M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $287.56M | |
| CFI | -$35.18M | |
| CFF | -$253.91M | |
| Capex | $31.01M | |
| Free Cash Flow | $256.55M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Evercore ISI Group | → | |
| Argus Research | → | |
| Wells Fargo | → | |
| UBS | → | |
| TD Cowen | → | |
| Evercore ISI Group | → | |
| RBC Capital | → | |
| Citigroup | → | |
| RBC Capital | → | |
| Scotiabank | → |
Analyst sentiment
Institutional ownership
Screeners with TECH
Data Sources & References
- TECH Official Website www.bio-techne.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/842023/000110465925107053/0001104659-25-107053-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/842023/000155837025011716/0001558370-25-011716-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- TECH Profile on Yahoo Finance finance.yahoo.com/quote/TECH
- TECH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tech
FAQ
What is the ticker symbol for Bio-Techne Corporation?
The ticker symbol for Bio-Techne Corporation is NASDAQ:TECH
Does Bio-Techne Corporation pay dividends?
Yes, Bio-Techne Corporation pays dividends. The last payment was $0.08, with an ex-dividend date on November 17, 2025
What sector is Bio-Techne Corporation in?
Bio-Techne Corporation is in the Healthcare sector
What industry is Bio-Techne Corporation in?
Bio-Techne Corporation is in the Biotechnology industry
What country is Bio-Techne Corporation based in?
Bio-Techne Corporation is headquartered in United States
When did Bio-Techne Corporation go public?
Bio-Techne Corporation initial public offering (IPO) was on February 9, 1989
Is Bio-Techne Corporation in the S&P 500?
Yes, Bio-Techne Corporation is included in the S&P 500 index
Is Bio-Techne Corporation in the NASDAQ 100?
No, Bio-Techne Corporation is not included in the NASDAQ 100 index
Is Bio-Techne Corporation in the Dow Jones?
No, Bio-Techne Corporation is not included in the Dow Jones index
When was Bio-Techne Corporation last earnings report?
Bio-Techne Corporation's most recent earnings report was on November 5, 2025
When does Bio-Techne Corporation report earnings?
The next expected earnings date for Bio-Techne Corporation is February 9, 2026
